Company intelligence / Profile preview

Cooler Heads

San Diego, California, United Statescoolerheads.com ↗

Ownership: Private
Development stage: Commercial

Overview

Amma™, FDA-cleared in 2021, is the world's first patient-administered portable scalp cooling system that helps cancer patients undergoing chemotherapy preserve their hair. The device has shown strong market adoption with more than 20 cancer centers implementing the technology since its commercial launch in late summer 2022.

Therapeutic areas: Oncology
Modalities: Medical device (scalp cooling system)
Industry: Therapeutic Medical Devices

Partnerships

McKesson (distribution agreement)US Oncology network

Beyond the preview

Go deeper on Cooler Heads.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cooler Heads.

Explore the full profile